Article
Common and rare variants in complement genes as biomarkers of COVID-19 infection and severity. A lesson to learn for emerging pathogens.
Frontiers in immunology - 1 Jan 2026
De La Morena-Barrio María Eugenia, Van Den Rym Ana, Escorial Sanz Olga, Corvillo Fernando, García-Sánchez Rosario, González-Sánchez Laura, Muñoz-Barrera Adrián, González-Montelongo Rafaela, Lorenzo-Salazar José Miguel, Flores Carlos, de Andrés-Martín Ana, Rodríguez-Gallego Carlos, Allende Luis, Alsina Laia, Sánchez-Ramón Silvia, López-Collazo Eduardo, López-Trascasa Margarita, Sánchez-Corral Pilar, Pérez de Diego Rebeca, Corral de la Calle Javier, López-Lera Alberto
Abstract excerpt
Introduction: The first wave of Coronavirus disease 2019 (COVID-19), driven by the global emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), severely affected Spain with high infection and mortality rates across the country. Although numerous common and rare genetic variants affecting immune-related pathways have been associated with susceptibility to infection and severe disease, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
